Her writing focuses on gene editing technology, cell and gene therapies, and the regulatory space.

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery.” ...

Keep abreast with the latest news related to Cell-Free DNA (cfDNA) Application in Cancer Detect there are 68 news items on Cell-Free DNA (cfDNA) Application in Cancer Detect that covers updates ...

Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

"Further investigation of cfDNA-sequencing patterns would help to identify the subgroup of persons with nonreportable results who might have cancer." A cell-free DNA test, or cfDNA, is a test of ...

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening ... who initially received unusual or nonreportable clinical cfDNA-sequencing results, the IDENTIFY study showed.

Taken together, our results suggest that in addition to physiological age, comorbidities and unfavorable clinical traits, intense surgical ...

Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies including molecular reference standards, today announces the launch of its first ...

Aldevron’s Alchemy™ is an exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with cleaner ...